Clinical trial
MVA Post-Event: Administration Timing and Boost Study
NCT00437021 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00437021 |
|---|---|
| Title | MVA Post-Event: Administration Timing and Boost Study |
| Official title | Evaluation of IMVAMUNE® Smallpox Vaccine With Respect to Safety and Optimization of Immune Responses by Different Vaccination Regimens in Vaccinia-Naïve Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Smallpox |
| Intervention type | Biological, Other |
| Interventions | Live vaccinia virus vaccine, MVA Smallpox Vaccine, Placebo |
| Enrollment | 226 |
| Start date | Apr 16, 2007 |
| Primary completion | Apr 21, 2009 |
| Completion | Apr 21, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | Sep 19, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: